Safety and Tolerability of SARS-CoV-2 Emergency-Use Authorized Vaccines Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) is a novel coronavirus emerging from Wuhan, China that can cause severe respiratory illness and a myriad of other complications that is now known as COVID-19. This disease was declared a pandemic by World Health Organization in March 2020 and has affected hundreds of millions of people worldwide1. COVID-19  clinical presentations can vary greatly between patients and those who are at highest risk for severe illness leading to hospitalization and/or death include older age, obesity, diabetes, and immunocompromised state, amongst other conditions2.

Source: Biology of Blood and Marrow Transplantation - July 15, 2021 Category: Hematology Authors: Haris Ali, Dat Ngo, Ahmed Aribi, Shukaib Arslan, Sanjeet Dadwal, Guido Marcucci, Ryotaro Nakamura, Stephen J. Forman, Jason Chen, Monzr M. Al Malki Source Type: research